iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
0.9265
-0.0618 (-6.25%)
At close: Jun 5, 2025, 4:00 PM
0.8901
-0.0364 (-3.93%)
After-hours: Jun 5, 2025, 4:17 PM EDT

iBio, Inc. Statistics

Total Valuation

iBio, Inc. has a market cap or net worth of $14.71 million. The enterprise value is $14.23 million.

Market Cap 14.71M
Enterprise Value 14.23M

Important Dates

The last earnings date was Friday, May 2, 2025, before market open.

Earnings Date May 2, 2025
Ex-Dividend Date n/a

Share Statistics

iBio, Inc. has 16.52 million shares outstanding. The number of shares has increased by 376.23% in one year.

Current Share Class 16.52M
Shares Outstanding 16.52M
Shares Change (YoY) +376.23%
Shares Change (QoQ) +7.99%
Owned by Insiders (%) 2.60%
Owned by Institutions (%) 15.78%
Float 15.84M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 23.84
Forward PS 145.76
PB Ratio 0.87
P/TBV Ratio 2.82
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 37.94
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.38.

Current Ratio 1.12
Quick Ratio 0.92
Debt / Equity 0.38
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -73.74

Financial Efficiency

Return on equity (ROE) is -90.83% and return on invested capital (ROIC) is -35.91%.

Return on Equity (ROE) -90.83%
Return on Assets (ROA) -30.35%
Return on Invested Capital (ROIC) -35.91%
Return on Capital Employed (ROCE) -122.67%
Revenue Per Employee $23,438
Profits Per Employee -$1.31M
Employee Count 16
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -64.33% in the last 52 weeks. The beta is 0.94, so iBio, Inc.'s price volatility has been similar to the market average.

Beta (5Y) 0.94
52-Week Price Change -64.33%
50-Day Moving Average 1.41
200-Day Moving Average 2.55
Relative Strength Index (RSI) 43.05
Average Volume (20 Days) 510,326

Short Selling Information

The latest short interest is 656,763, so 3.98% of the outstanding shares have been sold short.

Short Interest 656,763
Short Previous Month 925,508
Short % of Shares Out 3.98%
Short % of Float 4.15%
Short Ratio (days to cover) 0.31

Income Statement

In the last 12 months, iBio, Inc. had revenue of $375,000 and -$20.99 million in losses. Loss per share was -$2.32.

Revenue 375,000
Gross Profit 375,000
Operating Income -16.81M
Pretax Income n/a
Net Income -20.99M
EBITDA -16.02M
EBIT -16.81M
Loss Per Share -$2.32
Full Income Statement

Balance Sheet

The company has $4.96 million in cash and $4.32 million in debt, giving a net cash position of $639,000 or $0.04 per share.

Cash & Cash Equivalents 4.96M
Total Debt 4.32M
Net Cash 639,000
Net Cash Per Share $0.04
Equity (Book Value) 11.38M
Book Value Per Share 1.13
Working Capital 663,000
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$15.54 million and capital expenditures -$225,000, giving a free cash flow of -$15.77 million.

Operating Cash Flow -15.54M
Capital Expenditures -225,000
Free Cash Flow -15.77M
FCF Per Share -$0.95
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -4,483.47%
Pretax Margin -4,389.33%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

iBio, Inc. does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -376.23%
Shareholder Yield -376.23%
Earnings Yield -141.20%
FCF Yield -106.06%

Analyst Forecast

The average price target for iBio, Inc. is $4.87, which is 446.88% higher than the current price. The consensus rating is "Strong Buy".

Price Target $4.87
Price Target Difference 446.88%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -31.30%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on November 29, 2023. It was a reverse split with a ratio of 0.05:1.

Last Split Date Nov 29, 2023
Split Type Reverse
Split Ratio 0.05:1

Scores

iBio, Inc. has an Altman Z-Score of -24.99 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -24.99
Piotroski F-Score 2